1. Key Issues in Depression: Highlights From APA 2016

2.   New Research on Suicidality, Treatment Resistant Depression, and Cognitive Impairment

3. A Prospective Study of Antidepressant Adherence and Suicide Risk

4. A Prospective Study of Antidepressant Adherence and Suicide Risk: Results

5. Treatment Resistant Depression (TRD) Diagnostic Profile and Therapeutic Role of Antipsychotics And Mood Stabilizers

6. Treatment Resistant Depression Results

7. Impact of Vortioxetine on Functional Capacity in MDD Patients With Cognitive Dysfunction: A UCSD Performance-based Skills Assessment Post-hoc Analysis

8. Functional Capacity Results

9. New Research on Brexpiprazole, Levomilnacipran, and Cognition

10. Residual Patient-Reported Cognitive Dysfunction: A Potential Predictor for Relapse in MDD?

11. Residual Patient-Reported Cognitive Dysfunction: A Potential Predictor for Relapse in MDD? (cont)

12. Effect of Adjunctive Brexpiprazole on Cognitive and Physical Functioning in Five Exploratory, Open-Label Studies on Major Depressive Disorder

13. Effect of Adjunctive Brexpiprazole Results

14. Direct and Indirect Effects of Levomilnacipran ER on Functional Impairments in MDD Patients With Cognitive Difficulties: Post-Hoc Path Analyses

15. Direct and Indirect Effects of Levomilnacipran ER Results

16. The Effect of Vortioxetine on Cognitive Dysfunction

17. Efficacy of Vortioxetine on Cognitive Function in Working Subjects With Major Depressive Disorder (Post-hoc Analysis)

18. Efficacy of Vortioxetine on Cognitive Function Results

19. Research on Depression With Mixed Features

20. Baseline Differences in Two Depressed Populations: Major Depression With Mixed Features Vs Bipolar I Depression

21. Baseline Differences in Two Depressed Populations (cont)

22. Baseline Differences in Two Depressed Populations (cont)

23. Clinical Characteristics, Comorbidities and Health Care Utilization Among Patients With Major Depressive Disorder With Mixed Features

24. Patients With Major Depressive Disorder With Mixed Features (cont)

25. Lurasidone for Major Depressive Disorder With Mixed Features: Effect of Irritability, Post Hoc Analysis

26. Lurasidone for Major Depressive Disorder With Mixed Features: Effect of Irritability, Post Hoc Analysis Results

27. Abbreviations

28. Abbreviations (cont)

29. Abbreviations (cont)